Drugmakers, Insurers Spend Millions on Drug-Pricing Blame Game
Congressional criticism of pharmaceutical industry middlemen has created a rush of spending on lobbying and advertising as insurers and drugmakers battle over blame for the price of medicine in the US. But not all pharmacy benefits managers say they oppose the legislative efforts. Robyn Crosson, vice president of government relations for Navitus Health Solutions, said the company was “quite supportive” of the bipartisan efforts.
View the Article Online